Disc Medicine, Inc. (IRON) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 1 Strong Buy, 10 Buy.
The consensus price target is $110.25 (low: $75.00, high: $153.00), representing an upside of 56.4% from the current price $70.48.
Analysts estimate Earnings Per Share (EPS) of $-4.11 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.96 vs est $-4.11 (beat +3.8%). 2025: actual $-6.01 vs est $-6.00 (missed -0.2%). Analyst accuracy: 98%.
IRON Stock — 12-Month Price Forecast
$110.25
▲ +56.43% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Disc Medicine, Inc., the average price target is $110.25, with a high forecast of $153.00, and a low forecast of $75.00.
The average price target represents a +56.43% change from the last price of $70.48.
Highest Price Target
$153.00
Average Price Target
$110.25
Lowest Price Target
$75.00
IRON Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to Disc Medicine, Inc. in the past 3 months
EPS Estimates — IRON
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.96
vs Est –$4.11
▲ 3.9% off
2025
Actual –$6.01
vs Est –$6.00
▼ 0.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — IRON
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
